ベインのウェブサイトは、ユーザーの、利便性の向上、と機能改善のために、クッキーを使用しています。詳細は、弊社のプライバシーポリシーをご参照ください。このサイト閲覧を継続されることで、クッキーの使用についてご了承いただいたことになります。

Medtech Dive

Medtechs eye key role of ASCs in return of elective care

Medtechs eye key role of ASCs in return of elective care

The flight of joint replacements and other lucrative procedures from acute care hospitals to ambulatory surgery centers was happening before the COVID-19 pandemic, but the crisis may prove to accelerate the trend

  • 2020年5月26日
  • min read

Medtech Dive

Medtechs eye key role of ASCs in return of elective care

The flight of joint replacements and other lucrative procedures from acute care hospitals to ambulatory surgery centers was happening before the COVID-19 pandemic, but the crisis may prove to accelerate the trend.

“That shift was underway, but not very quickly: things never are in healthcare,” said Tim van Biesen, head of Bain & Company’s global healthcare practice.

Some 5,700 ASCs in the U.S. carried out 23 million procedures in 2018, according to data cited by Bain last fall. The year prior, ASCs reportedly carried out more than half of all outpatient surgeries, versus having 32% share 15 years ago.

Medtech Dive